๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

New oncogene for bladder cancer

โœ Scribed by Kathryn Senior

Book ID
117783162
Publisher
The Lancet
Year
2004
Tongue
English
Weight
150 KB
Volume
5
Category
Article
ISSN
1470-2045

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Oncogenes and Bladder Cancer
Oncogenes and Bladder Cancer
โœ P. R. MALONE; K. V. VISVANATHAN; B. A. J. PONDER; R. J. SHEARER; I. C. SUMMERHAY ๐Ÿ“‚ Article ๐Ÿ“… 1985 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 351 KB
Oncogenic FGFR3 gene fusions in bladder
Oncogenic FGFR3 gene fusions in bladder cancer
โœ Williams, S. V.; Hurst, C. D.; Knowles, M. A. ๐Ÿ“‚ Article ๐Ÿ“… 2012 ๐Ÿ› Oxford University Press ๐ŸŒ English โš– 893 KB
New treatments for superficial bladder c
New treatments for superficial bladder cancer
โœ Jay B. Shah; Gina M. Badalato; James M. McKiernan ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› Current Science Inc. ๐ŸŒ English โš– 219 KB
Ras oncogene point mutations in bladder
Ras oncogene point mutations in bladder cancer resistant to cisplatin
โœ Wood, D. P. ;Anderson, A. E. ;Fair, R. ;Chaganti, R. S. K. ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› Springer ๐ŸŒ English โš– 486 KB

Bladder tumors respond to cisplatin-based chemotherapy in 68% of cases, but only 30% will have a durable response. Recent studies have suggested that ras point mutations may produce cisplatin drug resistance in cell lines. To determine the role of ras point mutations in human tumors resistant to cis

A NEW TUMOR MARKER FOR BLADDER CANCER
A NEW TUMOR MARKER FOR BLADDER CANCER
โœ Kenkichi Koiso; Hideyuki Akaza; Mikinobu Ohtani; Naoto Miyanaga; Kazumasa Aoyagi ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 907 KB